Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are under 26 years old
- A doctor has diagnosed you with atopic dermatitis (eczema)
- If you are 18 or older, you are willing and able to sign a consent form yourself
- If you are under 18, a parent or legal guardian is willing to sign a consent form on your behalf
- You (and/or your parent or legal guardian) are willing to be contacted by the study team in the future
- You have been seen for medical care at Johns Hopkins since January 1, 2017
- You are currently taking, have previously taken, or are planning to start (within the next 6 months) a systemic treatment for atopic dermatitis — meaning a medication that works throughout the whole body, such as a pill or injection (confirm with trial site)
Who may not be able to join:
- You are 26 years old or older at the time of signing up for the registry
- You do not speak English
- You are under 18 and your main caregiver does not speak English
- You are under 18 and your parent or legal guardian is not willing to sign the consent form
- You are a foster child
- You have not received care at Johns Hopkins since January 1, 2017
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joy Wan, MD MSCE, Johns Hopkins University
Phone: 1 (848) 702-4101
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment effectiveness as assessed by the change in Investigator's Global Assessment (IGA) Scores; Treatment effectiveness as assessed by the change in Eczema Area and Severity Index (EASI) Scores; Treatment effectiveness as assessed by the change in Patient Oriented Eczema Measure (POEM) Scores; Treatment effectiveness as assessed by the change in Patient-Reported Outcomes Measurement Information System (PROMIS) Itch questionnaire score; Treatment effectiveness as assessed by the change in Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety questionnaire score; Treatmen...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.